advertisement
Surgical Treatment Editor's Selection
326 comments — showing 1 to 25 · all topics
Is the Hydrus Microstent cost-effective for mild-to-moderate POAG?
Ricardo Paletta Guedes on: Cost-Effectiveness Analysis of Hydrus Microstent for Patients with Mild to Moderate Primary Open-Angle Glaucoma in Canada IGR 26-1 | 2026
Trabeculectomy vs tube shunt in uveitic glaucoma: similarly high failure rates
Eleonora Micheletti on: The Rate of Failure of Trabeculectomy and Tube Shunt Surgery in Eyes with Uveitic Glaucoma and Ocular Hypertension IGR 26-1 | 2026
One-Year Real-World Outcomes of the XEN Gel Stent
Oluwademilade Osawe & Pouya Alaghband on: One-Year Real-World Outcomes of Ab-Externo Gel Stent Placement From the EXPAND Study IGR 25-4 | 2026
PAUL Glaucoma Implant for uveitic glaucoma: 3-year outcomes
Ewald Lindner on: The PAUL Glaucoma Implant in the management of uveitic glaucoma-3-year follow-up IGR 25-4 | 2026
Combined SPI + goniosynechialysis + goniotomy for advanced PACG: 2-year data
Bryan Ang on: Two-year outcomes of combined surgical peripheral iridectomy, goniosynechialysis, and goniotomy for advanced primary angle-closure glaucoma without cataract: A multicenter study IGR 25-3 | 2025
SIBS microshunt, gel stent, or trabeculectomy: which wins?
Pradeep Ramulu on: Glaucoma Surgery Comparison: SIBS Microshunt Versus Gelatin 45 µm Microstent Versus Trabeculectomy as Primary Surgical Interventions IGR 25-3 | 2025
XEN-45 Gel stent implantation is effective and safe
Sunee Chansangpetch & Shan Lin on: Clinical study on the efficacy and safety of glaucoma drainage implants in the treatment of different types of glaucoma IGR 25-3 | 2025
MIGS and MIBS take center-stage vs. traditional surgery
Michele Figus & Chiara Posarelli on: Trends in glaucoma surgery in a tertiary hospital in Spain: 2010-2022 IGR 25-1 | 2025
Sectorial cyclodialysis with bio-scaffold scleral reinforcement to enhance uveoscleral outflow and reduce IOP
Patrick Wu & Robert Feldman on: Bio-Interventional Cyclodialysis and Allograft Scleral Reinforcement for Uveoscleral Outflow Enhancement in Open-Angle Glaucoma Patients: One-Year Clinical Outcomes IGR 25-1 | 2025
Outcomes of gonioscopy-assisted Trabeculotomy
Xiulan Zhang & Zefeng Yang on: Gonioscopy-Assisted Transluminal Trabeculotomy Outcomes Under Different Levels of Glaucoma Severity: A Multicenter, Comparative Study IGR 24-4 | 2024
Clinical outcomes in aqueous misdirection syndrome
Luciano Quaranta on: Aqueous misdirection syndrome: clinical outcomes and risk factors for treatment failure IGR 24-4 | 2024
Dual-blade Goniotomy vs. Ab-interno Trabeculotomy
Tanuj Dada & Shalini Mohan on: Randomised clinical trial for morphological changes of trabecular meshwork between Kahook dual-blade goniotomy and ab interno trabeculotomy with a microhook IGR 24-3 | 2024
Ab-externo Microshunt vs. Trabeculectomy
Kin Sheng Lim & Bhavin Patel on: Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study IGR 24-3 | 2024
Ab-externo Microshunt vs. Trabeculectomy
Kaweh Mansouri on: Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: Two-Year Results from a Randomized, Multicenter Study IGR 24-3 | 2024
Do Preoperative Glaucoma Medications affect Surgical Outcomes?
Ronald Fellman & Davinder S. Grover on: Impact of glaucoma medications on subsequent Schlemm's canal surgery outcome: Cox proportional hazard model and propensity score-matched analysis IGR 24-3 | 2024
Does Intraoperative Bevacizumab affect Surgical Outcomes?
Carla Siegfried on: Intravitreal bevacizumab improves trabeculectomy survival at 12 months: the bevacizumab in trabeculectomy study-a randomised clinical trial IGR 24-3 | 2024
Trabectome and Trabeculectomy effects on Visual Acuity
Sameh Mosaed on: Comparison of Short-term Visual Acuity Changes After Trabeculotomy ab Interno Using Trabectome and Trabeculectomy ab Externo IGR 24-1/2 | 2024
Post-op Hypotony after Microshunt and Trabeculectomy
Anastasios E Sepetis & Nishani Amerasinghe on: Hypotony in the early postoperative period after MicroShunt implantation versus trabeculectomy: A registry study IGR 24-1/2 | 2024
Xen 45: Four years later…
Michele Figus & Chiara Posarelli on: Four-Year Outcome of XEN 45 Gel Stent Implantation in a Swedish Population IGR 24-1/2 | 2024
post-op aqueous misdirection afer PACG surgery
Sasan Moghimi on: Incidence and characteristics of aqueous misdirection after glaucoma surgery in Chinese patients with primary angle-closure glaucoma IGR 24-1/2 | 2024
Iridotomy for Angle-Closure Prevention: 14-year outcomes
Alanna James & Benjamin Xu on: Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial IGR 23-4 | 2023
Iridotomy for Angle-Closure Prevention: 14-year outcomes
Sasan Moghimi on: Fourteen-Year Outcome of Angle-Closure Prevention with Laser Iridotomy in the Zhongshan Angle-Closure Prevention Study: Extended Follow-up of a Randomized Controlled Trial IGR 23-4 | 2023
Stent vs. Hole: Insights from GPS
Kaweh Mansouri on: Gel Stent Versus Trabeculectomy: The Randomized, Multicenter, Gold-Standard Pathway Study (GPS) of Effectiveness and Safety at 12 Months IGR 23-4 | 2023
Drainage Biostent
Antonio Fea on: Biotissue stent for supraciliary outflow in open-angle glaucoma patients: surgical procedure and first clinical results of an aqueous drainage biostent IGR 23-4 | 2023
Microhook Trabeculotomy vs. Dual Blade Goniotomy
Ronald Fellman & Davinder S. Grover on: Comparison of Mid-Term Outcomes between Microhook ab Interno Trabeculotomy and Goniotomy with the Kahook Dual Blade IGR 23-4 | 2023
Browse
This issue
advertisement
